ADC Therapeutics (NYSE:ADCT) Cut to Underperform at Bank of America

Bank of America lowered shares of ADC Therapeutics (NYSE:ADCT – Get Rating) from a neutral rating to an underperform rating in a report released on Monday, The Fly reports. ADCT has been the topic of several other research reports. Royal Bank of Canada lowered their target price on shares of ADC Therapeutics from $18.00 to […]

Related Keywords

Canada ,United States ,America , ,America Corp ,Royal Bank ,Blue Owl Capital Holdings ,Millennium Management ,Morgan Stanley ,Moneta Group Investment Advisors ,Therapeutics Company Profile ,Get Rating ,Moderate Buy ,Group Investment Advisors ,Owl Capital Holdings ,Adc Therapeutics ,Nyse Adct ,Hadct ,Medical ,Downgrade ,Bank Of America Co ,